About the Epidemiology and Genetics Research Program
Epidemiology is the scientific study of the causes and distribution of disease in populations. The National Cancer Institute's (NCI) Epidemiology and Genetics Research Program (EGRP), in the Division of Cancer Control and Population Sciences (DCCPS), provides opportunities for investigators to increase understanding of cancer causes and prevention in human populations.
EGRP supports research in four areas:
- Clinical and translational epidemiology, including etiologic and genomic factors that influence cancer progression, recurrence, survival, and other treatment outcomes, and factors associated with cancer development among individuals with underlying diseases and conditions;
- Host susceptibility factors that influence personal susceptibility to cancer in humans, such as genetic, epigenetic, immunological, hormonal, and biological pathways; and social, cultural, racial, and ethnic factors;
- Methods and technologies for epidemiologic data collection, study design and analysis, and development and adaptation of laboratory and technical approaches for large studies in human populations; and
- Modifiable risk factors to reduce cancer risk in humans, including exposures to nutritional components; physical activity and energy balance; alcohol and tobacco; and infectious, physical, and chemical agents.
EGRP is the largest funder of cancer epidemiology grants nationally and worldwide. View current funding opportunities for cancer epidemiology and genetics research.
